Oxygen or sulfur containing heteroaromatics as factor Xa...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C548S236000

Reexamination Certificate

active

06962935

ABSTRACT:
The present application describes oxygen and sulfur containing heteroaromatics and derivatives thereof of formula I:or pharmaceutically acceptable salt or prodrug forms thereof, wherein J is O or S and D may be C(═NH)NH2, which are useful as inhibitors of factor Xa.

REFERENCES:
patent: 5103014 (1992-04-01), Musser et al.
patent: 5317103 (1994-05-01), Baker et al.
patent: 5463071 (1995-10-01), Himmelsbach et al.
patent: 5514696 (1996-05-01), Murugesan et al.
patent: 5612359 (1997-03-01), Murugesan
patent: 5658909 (1997-08-01), DeBernardis et al.
patent: 5668159 (1997-09-01), Jin et al.
patent: 5691329 (1997-11-01), DeGrado et al.
patent: 0513387 (1992-11-01), None
patent: 0768305 (1997-04-01), None
patent: WO 9424095 (1994-10-01), None
patent: WO 9514683 (1995-06-01), None
patent: WO 9518111 (1995-07-01), None
patent: WO 9638426 (1996-12-01), None
patent: WO 9747299 (1997-12-01), None

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Oxygen or sulfur containing heteroaromatics as factor Xa... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oxygen or sulfur containing heteroaromatics as factor Xa..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxygen or sulfur containing heteroaromatics as factor Xa... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3470579

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.